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CytoskeletonThe attachment of organelles to the cytoskeleton and directed organelle transport is essential for cellular
morphology and function. In contrast to other cell organelles like the endoplasmic reticulum or the Golgi
apparatus, peroxisomes are evenly distributed in the cytoplasm, which is achieved by binding of peroxisomes
to microtubules and their bidirectional transport by the microtubule motor proteins kinesin-1 (Kif5) and cyto-
plasmic dynein. KifC3, belonging to the group of C-terminal kinesins, has been identiﬁed to interact with the
human peroxin PEX1 in a yeast two-hybrid screen.We investigated the potential involvement of KifC3 in perox-
isomal transport. Interaction of KifC3 and the AAA-protein (ATPase associated with various cellular activities)
PEX1 was conﬁrmed by in vivo colocalization and by coimmunoprecipitation from cell lysates. Furthermore,
knockdown of KifC3 using RNAi resulted in an increase of cellswith perinuclear-clustered peroxisomes, indicating
enhanced minus-end directed motility of peroxisomes. The occurrence of this peroxisomal phenotype was cell
cycle phase independent, while microtubules were essential for phenotype formation. We conclude that KifC3
may play a regulatory role inminus-end directed peroxisomal transport for example by blocking themotor func-
tion of dynein at peroxisomes. Knockdownof KifC3would then lead to increasedminus-end directedperoxisomal
transport and cause the observed peroxisomal clustering at the microtubule-organizing center.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Bidirectional transport of organelles, vesicles, protein complexes and
mRNA by motor proteins is essential for cellular morphology and func-
tion. Myosins that move along microﬁlaments are responsible for slow
short-range transport whereas the microtubule motors of the kinesin
superfamily and cytoplasmic dynein perform long-range movements
in mammalian cells. Compared to dynein, representing a minus-motor
and therefore transporting cargoes to the cell center, the kinesin's direc-
tion of transport is dependent on the position of their motor domain
[1,2]. N-kinesins, like the so-called conventional kinesin (kinesin-1,
Kif5), harbor their motor domain at the N-terminus and are involved
in plus-end directed transport to the cell periphery whereas C-kinesins
are typically minus-motors. In contrast to other cell organelles like the
Golgi apparatus or the endoplasmic reticulum, peroxisomes are evenlydiverse cellular activities; CLIP,
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odt).
ights reserved.distributed inmammalian cells due to binding of peroxisomes to micro-
tubules [3–5] and transport of peroxisomes alongmicrotubules inmam-
malian and Drosophila cells by the motor proteins cytoplasmic dynein
and kinesin-1 [6–9]. Live cell imaging after staining with ﬂuorescent
dyes [6,10] revealed that only a small part of peroxisomes is directed
by microtubule-associated motor proteins in a fast long-range manner
[4,5].
Besides uniform cellular distribution, peroxisomal motility also
allows response to varying metabolic conditions by transport to certain
cellular areas. Interactions of peroxisomeswith other cellular organelles
like the endoplasmic reticulum (ER) or lipid droplets have been shown
[11–13] and seem to play an important role in peroxisomal lipidmetab-
olism [14]. Furthermore, peroxisomes are able to interact and form com-
plex peroxisomal networks [6]. Recent live cell imaging data showed
long-range movements of peroxisomes resulting in close contacts with
other peroxisomes [15]. However, exchange of proteins or metabolites
between single peroxisomes has not been detected yet [15–17].
A yeast two-hybrid screen revealed KifC3, a kinesin family protein,
as potential binding partner of the AAA-protein (ATPase associated
with various cellular activities) PEX1. KifC3 is a C-terminal kinesin of
the kinesin-14 family and is ubiquitously expressed [18,19]. The corre-
sponding human gene is located on chromosome 16q13–q21 [20] a
locus that is also affected in Bardet–Biedl syndrome [21], which is char-
acterized by retinal dystrophy amongst other symptoms [22]. As KifC3
maps within the critical region of this disease and constitutes one of
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epithelium [23], involvement of KifC3 in Bardet–Biedl syndrome
was considered [20,23] but has not been conﬁrmed yet. However,
KifC3−/− knockout mice did not show any physiological phenotype
[24] appearing healthy and developing normally. Minus-end directed
motor activity of KifC3was followed in vitro and a role of KifC3 in api-
cal transport of TGN (trans-Golgi network)-derived vesicles was
shown in vivo in polarized MDCK II cells (Madin Darby canine
kidney) [19]. Xu et al. also postulated that KifC3 participates in posi-
tioning of the Golgi apparatus under cholesterol depleted conditions [25].
Mutations in the PEX1 gene are one of the most common causes of
Zellweger syndrome [26,27] and the identiﬁcation of KifC3 as potential
binding partner suggested involvement of this kinesin in peroxisomal
motility. The interaction of PEX1 and KifC3 was analyzed in vivo as
well as in vitro using coimmunoprecipitation. The role of KifC3 in perox-
isomal transportwas investigated bymeans of knockdown experiments
using KifC3-mRNA targeting siRNA and peroxisomes were analyzed for
their distribution.
2. Material and methods
2.1. Plasmids
The plasmid containing the coding sequence for human KifC3 in the
retroviral pLPCX vector and the plasmid coding for EGFP-taggedmurine
KifC3 in the C1 vector were kind gifts of George Stark (Cleveland, USA),
Masatoshi Takeichi (Kobe, Japan) and Nobutaka Hirokawa (Tokyo,
Japan) and have been described previously [28,29]. The pDsRed2-ER
vector used for ﬂuorescent labeling of the endoplasmic reticulum
encodes the red ﬂuorescent protein DsRed2 fused to the ER-targeting
sequence of calreticulin and the ER retention sequence coding for KDEL
and was purchased from Clontech. PEX1-myc in pcDNA3.1zeo that
expresses the open reading frame of PEX1 with a C-terminal myc-tag
was a gift of Herma Portsteffen (Bochum, Germany). Changes to the
reference PEX1 sequence that do not affect complementation efﬁciency
are G90R and A113T.
2.2. Yeast two-hybrid screening
The human PEX1 open reading frame was ampliﬁed by PCR from
pBM65 using GD 311(5′-CGC GGA TCC GTT TGT GGG GCA GCG ATC
GCC TGG CG-3′) and GD 312 (5′-CGC GGA TCC TTA TGC TAA AGT TAC
TTT CTG TCC AGG TCG-3′) as primer and cloned into the BamHI site of
the yeast two-hybrid vector pGBKT7 (Clontech). This plasmid coding
for PEX1 N-terminally tagged with a GAL4 DNA-binding domain was
transformed into Saccharomyces cerevisiae AH 109 (mating type a)
using the lithium acetatemethod by Schiestl and Gietz [30]. The haploid
yeast strain Y187 (mating type α) carrying a HeLa cDNA library
(pGADT7-rec) was purchased from Clontech and the titer was deter-
mined with 1.38 ∗ 108 cfu/mL. After mating, interaction of proteins
resulted in expression of the GAL4 regulated reporter gens HIS3,
ADE2, lacZ and MEL1. Positive clones were ﬁrst selected using drop-
out plates TDO (-Leu/-Trp/-His) and QDO (-Leu/-Trp/-His/-Ade) and
then assayed forα-D-galactosidase and β-D-galactosidase activity. In
total 1.01 ∗ 107 clones were screened and the prey plasmid DNA of
162 positive clones was sequenced. All yeast two hybrid methods
followed the protocols as described in the Yeast Protocols Handbook
(Clontech PT3024-1).
2.3. Cell culture and transient DNA transfection
SV40T-transformed PEX1-deﬁcient human ﬁbroblasts (PBD009T)
[31] were a kind gift of Stephen Gould (Baltimore, USA). COS-7 (ATTC,
CRL-1651) and A549 cells (ATTC, CCL-185) were obtained from Hans
Probst (Tübingen, Germany). All cell lines were cultured at 37 °C and
8.5% CO2 in Dulbecco's modiﬁed Eagles' medium complemented with10% fetal calf serum, 2 mML-glutamine and 0.1 mM(50 mg/mL) genta-
micin. For transient DNA transfection cells in 25 cm2 dishes or ﬂasks
were treated with 5 μg plasmid DNA using jetPEI (PeqLab) according
to the manufacturer's instruction. The transfected cells were harvested
24 to 48 h post transfection or prepared for immunoﬂuorescence mi-
croscopy, respectively. The endoplasmic reticulum (ER) was labeled
by transfection of 1 μg pDsRed2-ER vector 24 h prior to ﬁxation,
accordingly.
Microtubuleswere depolymerized by treating COS-7 cells with 5 μM
nocodazole (stock: 10 mM in DMSO (dimethyl sulfoxide)) for 4 h prior
to ﬁxation. Cytochalasin B was added at a concentration of 4 μM (stock:
10 mM inDMSO (dimethyl sulfoxide)) andwas incubated for 48 h until
cells were prepared for immunoﬂuorescence microscopy. Synchroniza-
tion of cells was achieved by adding 10 mM thymidine for 24 h prior to
ﬁxation.
2.4. Indirect immunoﬂuorescence
For indirect immunoﬂuorescence microscopy cells were seeded on
coverslips 24 h before preparation as described before [32]. Primary
antibodies were diluted as indicated and were applied to the cells for
30 min. After extensive washing cells were treated with secondary
goat or donkey α-mouse or α-rabbit antibodies conjugated with Alexa
Fluor 488 or Alexa Fluor 594 (Molecular Probes, Invitrogen) for 10 min.
Rabbit polyclonal antibodies against human KifC3 (ProteinTech
Group) were used in a 1:50 dilution. For detection of β-tubulin I + II
or α-tubulin monoclonal mouse antibodies (Sigma) were applied in a
1:100 dilution. Polyclonal antibodies, raised against the ﬁrst N-terminal
133 amino acids of human PEX14 in rabbit, were diluted 1:400 [33].
The sheep α-PMP70 antibodies were a kind gift of Stephen Gould and
were diluted 1:100. The myc-tag was detected using monoclonal mouse
antibodies (9B11, epitope: EQKLISEEDL) from Cell Signaling in a 1:2000
dilution. Monoclonal mouse α-EEA-1 and α-GM130 antibodies, pur-
chased from BD Biosciences, were diluted 1:100 and 1:50, respectively.
Actin ﬁlaments were detected using phalloidin, tagged with
tetramethylrhodamine B isothiocyanate (Sigma), in a dilution of
1:500 analogous to primary antibodies. For staining of mitochondria
cells were treated withMitoTracker Red CMXRos (Molecular Probes)
at a concentration of 37.6 μM in medium for 30 min at 37 °C prior to
ﬁxation.
Immunoﬂuorescence stained cells were analyzed using a Zeiss
Axiovert 200 M ﬂuorescence microscope equipped with an AxioPlan
Apochromat 1.4 63× oil objective and an AxioPlan Neoﬂuar 1.3 100×
oil objective and images were acquired with an AxioCam MRm camera
in combination with AxioVision 4.7.2 software.
2.5. siRNA knockdown
COS-7 cells were electroporated twice at a 24 h interval using
1 nmol (20 μM) siRNA (siKifC3 sense: 5′-GGCUGUGCACGAGAAUCU
ATT-3′, siKif5B sense: 5′-GCCUUAUGCAUUUGAUCGGTT-3′ or AllStars
Negative Control siRNA, Qiagen) as described before [32]. Cells were
harvested 24 h and 48 h after the second electroporation for RNA
extraction and protein analysis, respectively or prepared for immunoﬂu-
orescence staining 48 h after the second siRNA treatment.
2.6. RNA extraction, cDNA synthesis and quantitative real-time PCR
measurements
Total RNA of siRNA-treated COS-7 cells was extracted (RNA spin Kit,
PrepEase, USB) and 500 ng of total RNA were transcribed to cDNA
(iScript, BioRad) according to the manufacturer's instructions. For
relative quantiﬁcation of cDNA amounts real-time PCR reactions were
performed by use of MaximaTM SYBR Green/ROX qPCR Master Mix
(Fermentas) in the StepOne Plus Real-time PCR System (Applied
Biosystems) under following conditions: 50 °C for 2 min, 95 °C for
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melting curve analysis. Data were collected at the 60 °C step. The
mRNA knockdown levels of KifC3 and Kif5B were calculated via the
2−ΔΔct method using GAPDH (Glyceraldehyde 3-phosphate dehy-
drogenase) as reference [34]. The primer pairs were designed as:
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) forward:
5′-CATCAAGAAGGTGGTGAAGCAG-3′ and reverse: 5′-CATCAAGAA
GGTGGTGAAGCAG-3′ and for kinesin superfamily protein 5B (Kif5B)
forward: 5′-gagtgctgagattgattctgatg-3′ and reverse: 5′-cggagatctgcat
tatcacg-3′. The primer pair for the Kinesin superfamily protein
C3 (KifC3) was purchased from Qiagen (Hilden, Germany) as
QuantiTect®Primer Assay, Hs_KifC3_1_SG.
2.7. Western blotting
Cell extracts containing 40 μg of total protein were separated on 8%
SDS-PAGE gels, modiﬁed according to Laemmli [35]. Separated proteins
were transferred onto nitrocellulose membranes via semidry blotting
(BioRad) for 1 h at 20 V in 20 mM Tris, 150 mM Glycin, 1.73 mM SDS
and 20% (v/v) methanol. Membranes were blocked with 5% (w/v)
non-fat dry milk in TBS-Tween (1 M Tris, pH 7.4, 1 M NaCl, 0.1% (v/v)
Tween20) overnight at 4 °C. Rabbit polyclonal α-KifC3 antibodies
(Proteintech Group) were diluted 1:333 in TBS-Tween containing 5%
(w/v) non-fat dry milk and incubated for 2 h at room temperature.
For detection of MAPK (mitogen activated protein kinase) as loading
control mouse α-MAPK antibodies (QIAexpress® Tag•100, epitope of
MAP kinase 2: EETARFQPGYRS, Qiagen) were diluted 1:1000 in TBS-
Tween containing 5% (w/v) non-fat dry milk. After washing with TBS
and TBS-Tween membranes were decorated either with goat α-rabbit
or goat α-mouse antibodies conjugated with horseradish peroxidase
(Sigma) at a 1:15,000 dilution in TBS-Tween containing 5% (w/v) non-
fat drymilk. After conducting the samewashing proceduresmembranes
were developed by enhanced chemiluminescence (Pierce ECL Western
Blotting substrate) and exposed to a photosensitive ﬁlm (Amersham
Hyperﬁlm™ ECL, GE Healthcare).
2.8. Analysis of relative DNA content by ﬂow cytometry
COS-7 cells of a 35 mm dish were trypsinized 48 h after the second
siRNA treatment and washed with PBS buffer (10 mM Na2HPO4,
1.8 mM KH2PO4, 140 mM NaCl, 2.7 mM KCl). Cell pellets were
resuspended in 0.5 mL PBS and transferred into 4.5 mL ice cold 70%
(v/v) ethanol. After 2 h of ﬁxation on ice cells were washed again with
PBS buffer. Pelletswere resuspended in 1 mL of propidium iodide stain-
ing solution (PBS buffer containing 0.1% Triton X-100, 0.2 mg/mLRNAse
A and 50 μg/mL propidium iodide) and incubated for 15 min at 37 °C.
At least 104 stained cells were analyzed on a LSR II (BD Biosciences)
ﬂow cytometer and cell cycle phase subpopulations were quantiﬁed
using the FACS Diva Software.
2.9. Coimmunoprecipitation from cell lysates
For preparation of cell lysates COS-7 cells of a 25 cm2 ﬂask were
transiently transfected with 5 μg PEX1-myc and 2.5 μg pcDNA3.1zeo,
2.5 μg KifC3-pLPCX and 5 μg pcDNA3.1zeo or 5 μg PEX1-myc and
2.5 μg KifC3-pLPCX, respectively. 48 h after transfection cells were
harvested, washed twice with Hank's buffer and lysed for 30 min on
ice using buffer D (20 mM HEPES, 110 mM potassium acetate, 5 mM
sodium acetate, 2 mM magnesium acetate, 1 mM EDTA, pH 7.3) con-
taining 0.5% Triton X-100 (v/v), 0.5% BSA (w/v), 0.2% sodium
deoxycholic acid (w/v) and protease inhibitor cocktail (Sigma, 1:200).
After centrifugation for 15 min at 16,100 ×g and 4 °C supernatants
were subjected to coimmunoprecipitation.
For coimmunoprecipitation analysis Dynabeads® M-280 coupled to
sheep α-mouse IgG (Invitrogen) were used according to the
manufacturer's instruction. 50 μL beads were prepared as indicatedusing buffer D with 0.1% BSA (w/v) and incubated with mouse α-myc
antibodies (Cell Signaling) in a 1:100 dilution overnight at 4 °C. The
beads were washed using buffer D containing 0.1% BSA (w/v) and
0.5% Triton X-100 (v/v) and resuspended in 200 μL of cell lysates.
After incubation for 2 h at 4 °C the beads were separated by a magnet
and the supernatants were mixed with SDS-loading buffer (125 mM
Tris pH 6.8, 138 mMSDS, 10% (v/v) β-mercaptoethanol, 20% (v/v) glyc-
erin, 0.29 mM bromphenol blue) and heated to 80 °C for 5 min. After
several washing steps using buffer D containing 1% Triton (v/v), 0.5%
BSA (w/v), 0.2% sodium deoxycholic acid (w/v) and protease inhibitor
cocktail (Sigma, 1:200) SDS-loading buffer was added to the beads,
heated to 80 °C for 5 min and the eluate was separated from the
beads. All samples were stored frozen at−20 °C.
3. Results
A yeast two-hybrid screen with human PEX1, an AAA-ATPase that
is involved in the late steps of peroxisomal matrix protein import,
revealed KifC3 as potential binding partner. To gain independent data
for the interaction of these proteins we coexpressed both proteins in
mammalian cells, analyzed their localization in vivo and performed
coimmunoprecipitations. Furthermore, KifC3 was transiently over-
expressed in COS-7 cells and knockdown experiments were performed
using RNAi to obtain information on KifC3 function in peroxisomal
motility.
3.1. PEX1 and KifC3 are able to interact in vivo
A HeLa cDNA library (1.38 ∗ 108 cfu/mL) in S. cerevisiae Y187 was
screened using PEX1 as bait. PEX1 (pGBKT7) was transformed into
AH109. The expressed prey proteins harbored the GAL4 transcription-
activating domain so that interaction of proteins resulted in expression
of GAL4 regulated reporter gens after mating of the two different yeast
strains. In total 107 clones were screened and the strains were mated
with an efﬁciency of 11%. After selection the prey plasmid DNA of 162
positive clones was sequenced.
Among the positive clones four different PEX6 fragments
(PEX6389–980, PEX6430–980, PEX6665–980 and PEX6706–980) could
be identiﬁed, indicating the principle functionality of this screen.
The shortest detected PEX6 fragment (PEX6706–980), comprising
the second AAA-domain D2 and the C-terminus, reﬂects the es-
sential PEX1 binding region. Tamura et al. [36] described a some-
what longer region in PEX6593–980 that showed a week interaction to
PEX1 using a yeast two-hybrid assay, although a stronger binding was
achieved if both AAA-domains were present. The binding of our detected
shorter PEX6 (PEX6706–980) fragment to PEX1 might just be strong
enough to be caught with the screen.
One potentially interesting candidate found was KifC3 that could
be identiﬁed four times. The interacting fragments all basically corre-
spond to the C-terminal 160 amino acids of KifC3 and cover the
C-terminal motor domain. Besides PEX6- and KifC3-fragments, several
cytoskeleton-associated proteins were found.
To test for in vivo interaction of PEX1 and KifC3, PEX1-deﬁcient
human ﬁbroblasts were transiently transfected with plasmids coding
for PEX1-myc and human KifC3, respectively. Cellular localization of
the expressed proteins was analyzed 48 h post transfection by indirect
immunoﬂuorescence microscopy (Fig. 1A). Overexpressed KifC3 local-
ized at microtubules conﬁrmed by colocalization with tubulin α stain-
ing whereas PEX1-myc was mainly detected at peroxisomes together
with PEX14 as a peroxisomal membrane protein marker. However,
coexpression of PEX1-myc and KifC3 resulted in amicrotubular staining
pattern of PEX1-myc colocalizing with KifC3 positive structures. This
indicates that PEX1 is able to interact with KifC3 in human ﬁbroblasts
when overexpressed. Coexpression of PEX1 and KifC3 in ΔPEX1 cells
did not abolish peroxisome complementation visualized byperoxisomal
localization of α-catalase and α-SKL antibodies, respectively. However,
AB
Fig. 1. KifC3 and PEX1 interact in vivo. (A) PEX1-deﬁcient human ﬁbroblasts were transiently transfected with PEX1-myc and human KifC3, either with one plasmid alone or in combina-
tion. 48 h after transfection cells were prepared for immunoﬂuorescence and incubated with α-KifC3, α-tubulin α, α-myc, α-PEX14 antibodies and the corresponding ﬂuorescence-
tagged secondary antibodies. Overexpressed KifC3 was localized at microtubules (compare Fig. 2) whereas PEX1-myc was mainly found at peroxisomes. Upon coexpression of KifC3
and PEX1-myc, PEX1-myc was detected at microtubules where it colocalized with KifC3. (B) Interaction of KifC3 and PEX1-myc was analyzed by coimmunoprecipitation (CoIp) using
cell lysates of COS-7 cells transiently expressing PEX1-myc and KifC3, either alone or in combination. PEX1-myc was captured to magnetic beads via α-myc antibodies and was able to
precipitate KifC3. Representative Western blots of CoIp input and supernatant samples (right panel) and eluates (left panel) using α-KifC3 and α-PEX1 antibodies are shown (repeated
four times). Intensity of KifC3 eluate bands was quantiﬁed and revealed an intensity doubling when PEX1-myc and KifC3 were expressed in combination (100%) compared to samples
expressing KifC3 alone (50%). Marked bands at 55 kDa (*) are caused by the applied IgGs and were used as loading controls for quantiﬁcation. Scale bar: 10 μm.
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expressing PEX1 alone (data not shown).
In addition, coimmunoprecipitation (CoIp) experiments were
performed. COS-7 cell lysates transiently expressing either PEX1-myc
or human KifC3, or both proteins in combination were treated with
α-myc antibodies coupled to magnetic beads to precipitate PEX1-myc.
KifC3 and PEX1 protein levels were analyzed using α-KifC3 and
α-PEX1 antibodies after SDS page and blotting onto nitrocellulose.
PEX1-myc successfully associated with the beads and KifC3 was eluted
in samples that coexpressed PEX1-myc andKifC3 (Fig. 1B, left panel), in-
dicating binding of PEX1 andKifC3 in vivo. Although KifC3 unspeciﬁcally
bound to the beads under various conditions (data not shown), it wassigniﬁcantly enriched in the presence of PEX1-myc in four independent
experiments. Quantiﬁcation of KifC3 eluate bands in Fig. 1B (left panel)
revealed an intensity doubling from 50% to 100% upon expression of
KifC3 and PEX1-myc compared to samples expressing KifC3 alone. The
observed shift of KifC3 bands to higher molecular weights in the input
and supernatant samples (Fig. 1B, right panel) is caused by high concen-
trations of BSA (bovine serum albumin) with similar molecular weight
used to minimize unspeciﬁc binding. For the same reason, no KifC3
double bands could be detected (compare Figs. 2B and 3A) in the eluate
samples (Fig. 1B, left panel) whereas replicates with reduced BSA levels
during CoIp elution showedKifC3 double bands indicating interaction of
PEX1 with different KifC3 isoforms (data not shown).
AB
C
Fig. 2. Localization of endogenous and overexpressed KifC3. (A) COS-7 cells were processed for immunoﬂuorescencemicroscopy usingα-KifC3 antibodies. During interphase endogenous
KifC3 localized near the nucleus and concentrated at perinuclear spots, whichweremost likely themicrotubule organizing center (MTOC) as indicated by tubulinα staining. Visualization
of peroxisomes by use of α-PMP70 antibodies did not reveal any colocalization of KifC3 with peroxisomes. During metaphase KifC3 was detected at the spindle ﬁbers and spindle poles.
(B) SDS-PAGE andwestern blot analysis usingα-KifC3 antibodies revealed distinct expression levels of endogenous KifC3 in different cell lines with highest expression levels in A549 and
COS-7 cells. To correct for the different loading of the total protein amount (HELA: 40 μg, A549: 10 μg, HEK 293T: 40 μg, HepG2: 40 μg, GM5756T: 40 μg, COS-7: 13 μg, COS-7 + KifC3:
83 ng) additional analysis with α-MAPK (mitogen activated protein kinase) antibodies is shown. (C) Overexpression of KifC3 in COS-7 cells resulted in a microtubular staining pattern
24 h after transient transfection conﬁrmed by colocalization with tubulin α. Just like endogenous KifC3, overexpressed KifC3 was not located at peroxisomes and it did not inﬂuence
the peroxisomal distribution. Scale bar: 10 μm.
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In order to reveal potential involvement of KifC3 in peroxisomal
transport or distribution we examined the localization of endogenous
KifC3. COS-7 cells were ﬁxed and prepared for immunoﬂuorescence
microscopy using α-KifC3 antibodies and Alexa Fluor 594 labeled
secondary antibodies. KifC3 showed diverse intracellular distributionpatterns depending on the corresponding cell cycle phase (Fig. 2A). In
interphase cells, KifC3 was localized near the nucleus and concentrated
at the centrosome as indicated by merging with the tubulin α staining
(Fig. 2A, ﬁrst row). This was not unexpected as KifC3, a C-terminal
kinesin, is supposed to function as a microtubule minus-motor and
has been detected at perinuclear regions in Caco2 cells [29]. In contrast,
mitotic cells, especially those in metaphase, showed an enhanced
A B
C
D
Fig. 3. Clustering of peroxisomes after knockdown of KifC3. COS-7 cells were electroporated twicewith siRNA targeting endogenous KifC3 orwith non-target control siRNA (sictr), respec-
tively. (A) Knockdown efﬁciencies onmRNA level were veriﬁed using quantitative real-time PCRmeasurements 24 h after the second electroporation (means and standard deviations are
shown). KifC3-mRNAwas reduced by 78 ± 0.08% (N = 14)whereasmRNA levels of Kif5B remained unaffected (N = 6). (B)Western blot analysis usingα-KifC3 antibodies andα-MAPK
antibodies as loading control revealed knockdown levels of KifC3 protein of 86 ± 12% (N = 11), a representative blot is shown. (C) 48 h after the second siRNA treatment cells were ﬁxed
and peroxisomes were stained using α-PEX14 antibodies. KifC3 knockdown samples showed increased amounts of cells with clustered peroxisomes compared to control cells whereas
knockdown of Kif5B (knockdown Kif5B mRNA: 78.6 ± 3.34%, N = 2) even reduced the amount of cells with clustered peroxisomes. Means and standard deviations (KifC3: N = 4)
or spreads (Kif5B: N = 2) are depicted. (D) Staining of peroxisomes and microtubules using α-PEX14 and α-tubulin α antibodies did not reveal any loss of microtubule-associated
peroxisomes upon KifC3 knockdown compared to control cells. Scale bars: 10 μm.
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row), which may argue for a role of KifC3 during cell division. Other
C-terminal kinesins like Kar3p in S. cerevisiae or XCTK2 in Xenopus laevis
are also known to be involved in mitosis or meiosis [37–40]. KifC3 was
more abundant in A549 (carcinomic human alveolar basal epithelial
cells) and COS-7 (immortalized kidney cells from African green mon-
key) cells compared to e.g. HepG2 (liver carcinoma derived human
epithelial cells) or HeLa (cervix carcinoma derived human epithelial
cells) cells (Fig. 2B). This is in accordance with published KifC3 expres-
sion proﬁles showing higher KifC3 levels in kidney and lung derived
tissues and lower KifC3 levels in tissues from liver and uterus of
human and mice [19,23,24]. However, human embryonic kidney cells
(HEK) seemed to express KifC3 at lower protein levels (Fig. 2B). The
used α-KifC3 antibody detected double bands at 70 kDa, as reported
before [25,28], which were veriﬁed to be speciﬁc for KifC3 protein by
detecting overexpressedhumanKifC3 in COS-7 cells. As the endogenous
KifC3 levels were highest in A549 and COS-7 cells, these cell lines were
used for further experiments. Endogenous KifC3 could not be detected
at peroxisomes in COS-7 cells marked by α-PMP70 antibodies (Fig. 2A,
second row). This could be due to the detection limit of ﬂuorescence
microscopy as only 5–10% of peroxisomes are actually moving along
microtubules [4,5] and motor proteins are transiently bound in small
amounts (1–10 molecules per peroxisome [7]).3.3. Overexpression of KifC3 did not affect peroxisomal distribution
To get insight into the role of KifC3 in peroxisomal transport, KifC3
was overexpressed and cells were analyzed for peroxisomal distribution.
COS-7 cellswere transiently transfectedwith plasmids coding for human
KifC3 and prepared for immunoﬂuorescence microscopy 24 h post
transfection. As depicted in Fig. 2C using primary α-KifC3 antibodies
and Alexa Fluor 594 labeled secondary antibodies, overexpressed KifC3
was localized to microtubules (compare also Fig. 1A). This indicates
that KifC3 is able to bind to microtubules and most likely functions as a
microtubule motor protein. Indeed, KifC3 minus-motor activity has
been conﬁrmed before in vitro as well as in vivo following transport of
TGN-derived vesicles [19]. Just like endogenous KifC3, overexpressed
KifC3 could not be detected at peroxisomes, which were visualized
using α-PMP70 antibodies (Fig. 2C, second row). The magniﬁcation
of the overlay (inlay, second row) shows that peroxisomes are often
located in close proximity to microtubules (in this case marked by
staining patterns of overexpressed KifC3) and aremost likely associated
with them. However, this overlap of peroxisomes with microtubules
seemed not to be enhanced in cells overexpressing KifC3 compared to
those harboring endogenous KifC3 levels (not shown).
Furthermore, overall peroxisomal distribution was not affected by
overexpression of either human KifC3 or murine EGFP-tagged KifC3
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cytoplasm. However, KifC3 overexpressing samples as well as control
samples transfected with the corresponding empty vectors showed a
small portion of cells with perinuclear-clustered peroxisomes of the
same magnitude. Peroxisomes are able to respond to alternating
metabolic needs and the observed clustering of peroxisomes in some
cells could represent secondary stress effects caused by the transfection
procedure and the overexpression of protein.
3.4. Knockdown of KifC3 led to perinuclear clustering of peroxisomes
As overexpression of KifC3 did not yield further information about
the function of KifC3 on peroxisomes, RNA interference was applied to
reduce KifC3 protein levels and cells were analyzed for a peroxisomal
distribution phenotype. COS-7 cells were electroporated twice with
siRNA targeting KifC3-mRNA, with siRNA targeting Kif5B-mRNA as pos-
itive control or with non-target control siRNA. Knockdown efﬁciencies
were controlled on mRNA and protein levels (Fig. 3A,B). Quantitative
real-time PCR revealed reduced KifC3-mRNA levels of 22.3 ± 0.08%
(N = 14) compared to control cells whereas Kif5B-mRNA levels
remained unaffected by siKifC3 treatment (Fig. 3A). Knockdown of
KifC3-mRNA decreased KifC3 protein levels by 86.4 ± 11.99% (N =
11) as exempliﬁed byWestern blot analysis of siRNA-treated cell lysates
using α-KifC3 antibodies with α-MAPK (mitogen-activated protein
kinase) antibodies as loading control (Fig. 3B).
To scan for KifC3 knockdown phenotypes, siRNA-treated cells were
ﬁxed 48 h after the second electroporation. Peroxisomes were visual-
ized using α-PEX14 antibodies and Alexa 594 labeled secondary anti-
bodies (Fig. 3C). The knockdown of KifC3 increased the number of
cells with perinuclear-clustered peroxisomes from 5% to 10% compared
to control cells whereas the number of peroxisomes per cell seemed to
remain constant. Microtubules were not affected by KifC3 knockdown
and peroxisomes were still associated with microtubules (Fig. 3D).
This indicates that microtubule minus-end directed peroxisomal motil-
ity is favored upon loweredKifC3 levels,which could be due to increased
activity of the microtubule minus-motor dynein. In contrast, siKif5B
treatment (knockdown Kif5B-mRNA: 78.6 ± 3.34%, N = 2) resulted
in an increased amount of cells with evenly distributed peroxisomes
and in less cells with perinuclear-clustered peroxisomes compared to
cells treated with control siRNA (Fig. 3C). Hence, peroxisomal minus-
end directed motility seemed to be decreased after Kif5B knockdown.
Actually, peroxisomal motility phenotypes have been reported after
knockdown or inhibition of the main peroxisomal motors kinesin-1
(Kif5) and dynein, respectively [6–8]. In these studies lowered amounts
or restricted activity of kinesin-1 or dynein decreased long-range perox-
isomal movements in both directions without affecting the even distri-
bution of peroxisomes in the cell. This has been explained by the so
called tug-of-war theory [41–43] which states that opposite polarity
motors have to be bound simultaneously at the same cargo to create a
certain kind of tension that is essential for bidirectional motility. If one
of these motors is missing or inactivated, this tension can no longer be
applied and motility is completely lost. In our case, knockdown ofTable 1
Overexpression of KifC3 did not inﬂuence peroxisomal distribution.
COS-7 cells were transiently transfected with the plasmids and cells with
clustered peroxisomes of one experiment were counted (only apparently
transfected cells were considered). At least 500 cells were analyzed.
Transfected plasmid Amount of cells with
clustered peroxisomes
KifC3(m)–pEGFP-C1 3.0%
pEGFP-N1 2.6%
KifC3(h)–pLPCX 1.2%
pcDNA3.1zeo 1.4%
(m): murine; (h): human.Kif5Bwould then result simultaneously in inactivation of dynein and re-
duced peroxisomal motility explaining the increase of cells with evenly
distributed peroxisomes (Fig. 3C).
3.5. Microtubules were necessary for peroxisomal clustering
In order to demonstrate that the observed increase of peroxisomal
clustering after KifC3 knockdown was indeed caused by a microtubule
motor and thuswas dependent on intactmicrotubules, the cytoskeleton
polymerization was manipulated. SiRNA-treated cells were incubated
either with nocodazole to depolymerize microtubules or with cytocha-
lasin B to disturb microﬁlament formation as indicated in Fig. 4A.
Controls were incubated with the same volume of DMSO, which was
used as solvent. DMSO-treated samples showed an increased amount
of cells with perinuclear-clustered peroxisomes after KifC3 knockdown
as described before (Fig. 4B). Furthermore, addition of cytochalasin B2
Fig. 4. Peroxisomal knockdown phenotype depends onmicrotubules. (A) Microtubules of
COS-7 cellswere depolymerized by incubationwith nocodazole (noc)whereas addition of
cytochalasin B (cyto B) degraded the actin skeleton. Controls were treated with DMSO,
which was used as solvent. Microtubules were visualized using α-tubulin α antibodies
and the actin skeleton was labeled by binding to rhodamine tagged phalloidin (ph–rh).
(B) SiRNA-treated COS-7 cells were incubated with cytochalasin B for 48 h, while
nocodazole was added 4 h prior to ﬁxation. Controls were treated with DMSO for the re-
spective times. Peroxisomes were stained using α-PEX14 antibodies. The observed in-
crease of cells with perinuclear-clustered peroxisomes after KifC3 knockdown was
independent of the actin skeleton, whereas microtubules were necessary. Cells with
clustered peroxisomes of one experimentwere quantiﬁed. At least 500 cellswere counted.
sictr: non-target control siRNA, scale bar: 10 μm.
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of this peroxisomal phenotype. Cells with clustered peroxisomes were
still increased upon lowered KifC3 levels compared to control cells.
Thus, the actin skeleton was not needed for minus-end directed perox-
isomal transport towards the centrosomeand the observed peroxisomal
clustering after KifC3 knockdown was independent of microﬁlaments.
In contrast, depolymerization of microtubules in siRNA-treated cells
prevented formation of the KifC3 knockdown mediated perinuclear
clustering of peroxisomes. In most cells peroxisomes were evenly
distributed and just a small part of cells was positive for the typical per-
oxisomal nocodazole phenotype [5,6,44] showing several small clusters
of peroxisomes throughout the cytosol. In KifC3 knockdown samples
as well as in control samples the same amounts of cells with the
nocodazole phenotype were counted, excluding the possibility that
these small clusters were generated from earlier KifC3 knockdown-
dependent perinuclear clusters. This led to the conclusion that microtu-
bules are necessary to transport peroxisomes to the centrosome where
the peroxisomal clusters are formed after KifC3 knockdown. These
results were reproduced several times using different nocodazole
incubation periods (data not shown).
3.6. The peroxisomal KifC3 knockdown phenotype was independent of the
cell cycle phase
Manymotor proteins, especially C-terminal kinesins, play important
roles in cell division and organization of microtubules. It is likely that
KifC3 is also involved in these processes. Hence, we wanted to exclude
the possibility that the observed peroxisomal clustering is caused by
accumulation of KifC3 knockdown cells in a certain cell cycle phase
e.g. by stabilization of microtubules. COS-7 cells treated with siRNA
were incubated with propidium iodide 48 h after the second electropo-
ration to label the DNA. These DNA-stained cells were then subjected to
ﬂow cytometry and the percentage of cells in the particular cell cycle
phases was determined (Fig. 5A). KifC3 knockdown cells as well as
control cells showed an equal distribution in different cell cycle phases.
The lowered KifC3 levels did not lead to accumulation in a certain cell
cycle phase. To conﬁrm these results COS-7 cells and A549 cells were
blocked in S-phase after siRNA treatment by addition of thymidine
and the peroxisomal distribution was analyzed (Fig. 5B). KnockdownFig. 5. Cell cycle phase dependency of peroxisomal clustering. DNA of siRNA-treated A549 and
histogram of ﬂuorescence intensities was recorded by ﬂow cytometry to quantify cells in a par
of KifC3 knockdownCOS-7 cells and control cells (sictr) did not show anydifferences concerning
with thymidine (thym) for 24 h to accumulate the cells in S-phase. The quantiﬁed relative amo
are depicted. The used thymidine block resulted in a shift of cell cycle phase distribution from G
were incubated with thymidine (as in B) and the amount of cells with clustered peroxisomes w
spreads (COS + thym, A549 ± thym: N = 2) are depicted. At least 500 cells were counted.of KifC3 in COS-7 and A549 cells increased the amount of cells with
perinuclear peroxisomal clustering (Fig. 5C). Accumulation of both cell
types in S-phase did not inﬂuence this increase of cells with clustered
peroxisomes in KifC3 knockdown samples. Consequently, alterations
in the distribution of cells in the particular cell cycle phases did not
affect formation of the peroxisomal phenotype indicating that the KifC3
knockdown phenotype is not cell cycle phase dependent. However, the
overall amount of cells with clustered peroxisomes was increased in
KifC3 knockdown samples as well as in control samples after thymidine
treatment. This might be induced by modiﬁed metabolic conditions due
to the thymidine incubation.
3.7. KifC3 knockdown also affected morphology of mitochondria and ER
It is known that kinesins and cytoplasmic dynein are able to bind
diverse cargoes and are involved in transport of different cellular organ-
elles. Therefore, themorphology and distribution of different organelles
was examined after KifC3 knockdown. COS-7 cells were treated with
siRNA as described before and prepared for immunoﬂuorescence
microscopy 48 h after the second electroporation. Peroxisomes, early
endosomes and the Golgi apparatus were detected using α-PEX14,
α-EEA-1 (early endosomal antigen-1) and α-GM130 antibodies,
respectively. Mitochondria were visualized by incubating the cells
with MitoTracker Red and the endoplasmic reticulum (ER) was labeled
by transfection with the pDsRed2-ER vector. The KifC3 knockdown not
only affected the distribution of peroxisomes, but also inﬂuenced the
morphology of mitochondria and the ER (Fig. 6). Mitochondria were
clustered near the nucleus to the same extent as peroxisomes. ER struc-
tures were also clearly accumulated in the same area though the single
tubular ER structures were still distributed throughout the cell and the
ER network was intact. Kinesin-1 and dynein not only are responsible
for bidirectional transport of peroxisomes but also constitute the princi-
ple motors for retrograde and anterograde transports of mitochondrial
and ER structures [45–49]. This argues for a mutual mechanism to
develop the KifC3 knockdown phenotype dependent on the minus-
motor dynein. In contrast, KifC3 knockdown did not inﬂuence the distri-
bution of early endosomes and the Golgi apparatus. The observed over-
lay ofα-GM130 andα-PEX14positive structures after KifC3 knockdown
(Fig. 6) resulted from the physiological localization of Golgi stacks at theCOS-7 cells was stained using propidium iodide 48 h after the second electroporation. A
ticular cell cycle phase corresponding to the amount of DNA. (A) Flow cytometry analysis
thedistribution of the cells in thedifferent cell cycle phases. (B) A549 cellswere incubated
unts of cells in the particular cell cycle phases of thymidine-treated and untreated samples
1- to S-phase and cells in S-phase were doubled. (C) SiRNA-treated A549 and COS-7 cells
as compared to unblocked cells. Means and standard deviations (COS − thym: N = 4) or
Fig. 6.Alteredmorphology ofmitochondria and the endoplasmic reticulumafter KifC3 knockdown. COS-7 cells were electroporated twicewith KifC3-siRNA andwith control siRNA (sictr),
respectively and prepared for immunoﬂuorescencemicroscopy 48 h after the second knockdown. Peroxisomes, early endosomes and theGolgi apparatuswere stained usingα-PEX14,α-
EEA-1 and α-GM130 antibodies. To mark mitochondria cells were incubated with MitoTracker Red CMXRos for 30 min and the endoplasmic reticulum (ER) was visualized by transient
transfection of the pDsRed2-ER vector 24 h prior ﬁxation. Mitochondria and ER are artiﬁcially colored in green. Scale bar: 10 μm.
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peroxisomes in the same region after reduced KifC3 levels. Xu et al.
showed that KifC3 was involved in positioning of the Golgi apparatus
under cholesterol depleted conditions [25]. However, no Golgi pheno-
type was observed in adrenocortical KifC3−/− knockout cells under a
physiological cholesterol level. We describe here perinuclear clustering
of peroxisomes, mitochondria and ER structures upon KifC3 knock-
down, indicating enhanced retrograde transport of these organelles,
most likely resulting from increased activity of theminus-motor dynein.
4. Discussion
The uniform distribution of peroxisomes in the cytosol is essential
for peroxisomal ROS (reactive oxygen species) protecting function and
transport of peroxisomes to a certain cellular area can be necessary
under speciﬁc metabolic conditions e.g. for peroxisomal lipid metabo-
lism [14] or to generate inter-peroxisomal contacts [15]. Bidirectional
transport of peroxisomes in mammalian and Drosophila cells is mainly
achieved by themotor proteins kinesin-1 (Kif5) and cytoplasmic dynein
[6–9]. We show here the involvement of the C-terminal kinesin KifC3 in
positioning of peroxisomes. In COS-7 cells used in this work KifC3 was
detected at microtubule minus-ends close to the nucleus at the
microtubule-organizing center (Fig. 2A). Overexpression of KifC3 led
to a prominent localization at microtubules and did not show any
alterations regarding the peroxisomal distribution (Fig. 2C). However,
knockdown of KifC3 by siRNA resulted in an increase of cells with
perinuclear-clustered peroxisomes from 5 to 10% (Fig. 3C). Depolymer-
ization of the cytoskeleton using nocodazole or cytochalasin B proved
the need of microtubules to form the KifC3-dependent peroxisomal
phenotype whereas microﬁlaments were not necessary.
Minus-end directed activity of KifC3 has been described in vitro and
in vivo by demonstrating participation of KifC3 in apical transport of
TGN-derived vesicles in polarized epithelial cells and by tracking of
EGFP-stained KifC3 in Caco2 cells [19,29]. Epithelial cells harbor apically
minus-end anchored microtubules in addition to centrosomal microtu-
bules. In these cells KifC3 was localized at microtubule minus-ends on
small cholesterol-rich vesicles directly beneath the plasma membrane
[19]. Expression of a dominant negative, motor domain-lacking KifC3
mutant resulted in loss of this apical KifC3 localization whereas
overexpression of intact KifC3 increased the apical appearance of KifC3.
Assuming KifC3 minus-motor activity at peroxisomes, one would
expect impaired microtubule minus-end directed transport after KifC3
knockdown resulting in increased plus-end directed transport and
clustering of peroxisomes in the cell periphery. Actually, increased
Golgi fragmentation has been observed in adrenocortical KifC3−/−
knockout mice under cholesterol-depleted conditions, which was
caused by reduced minus-end directed transport. On the other hand, if
KifC3 was involved in a tug-of-war, knockdown of KifC3 would not
lead to a peroxisomal distribution phenotype, as also described after
kinesin-1 knockdown (Fig. 3C and [7,8]), due to simultaneous inactiva-
tion of the opposite-directed motor protein. However, we could not
observe any of these expected peroxisomal phenotypes after KifC3
knockdown. Treatment of COS-7 and A549 cells with siRNA targeting
KifC3-mRNA rather seemed to enhance minus-end directed transport
of peroxisomes resulting in perinuclear peroxisomal clustering. Hence,
one can assume that KifC3 does not act as a typical minus-motor on
peroxisomal transport. In the following part different possibilities are
discussed that may explain the observed peroxisomal phenotype upon
KifC3 knockdown.
4.1. Is KifC3 involved in cell division?
Increased peroxisomal clustering after KifC3 knockdown could be
induced for example by secondary effects resulting fromKifC3 functions
during cell division. This idea is supported by the fact that KifC3 was
localized at spindle ﬁbers and spindle poles in mitotic cells (Fig. 2A).Actually, increased KifC3 expression levels have been detected in
docetaxel- and paclitaxel-resistant breast cancer cells counteracting
the microtubule stabilizing effect of these cytostatic drugs [28,50] and
suggesting a microtubule destabilizing function of overexpressed KifC3.
KifC3 knockdown could therefore lead to accumulation of cells in a
certain cell cycle phase e.g. by stabilization of microtubules. However,
ﬂow cytometry after staining of DNA with propidium iodide revealed
that KifC3 knockdown did not affect the distribution of the cells in the
different cell cycle phases (Fig. 5A). Accumulation of siRNA-treated
COS-7 and A549 cells in S-phase by adding thymidine did not inﬂuence
the occurrence of the KifC3 knockdown-dependent peroxisomal pheno-
type. This leads to the conclusion that the observed increase of cells with
perinuclear-clustered peroxisomes after KifC3 knockdown is formed
independently of the cell cycle phase. Not much is known about distri-
bution of peroxisomes inmammalian cells during cell division.Wiemer
et al. described stochastic disordered inheritance of peroxisomes in
CV-1 cells expressing GFP-PTS1 (peroxisomal targeting sequence-1) in
contrast to ordered inheritance by association to cytoskeletal elements
[5]. During mitosis peroxisomes were evenly distributed in these cells
and mostly not associated with microtubules. The peroxisomal popula-
tion seemed to be randomly divided between the two developing cells
by segregation of the cytoplasm. In contrast, Kredel et al. observed
peroxisomal clustering at mitotic spindle poles in HEK 293, HELA and
NIH3T3 cells after staining peroxisomes by expression of PTS-mRuby
suggesting ordered inheritance of peroxisomes [51]. However, our
data indicate that the observed perinuclear clustering of peroxisomes
after KifC3 knockdown is not correlated to mitosis.
4.2. Is KifC3 involved in binding of peroxisomes to microtubules?
Binding of peroxisomes to microtubules has been shown in vitro
as well as in vivo and binding capacity in vitro was dependent on
pH, temperature and ATP [4,10,52]. CLIP (cytoplasmic linker protein)
proteins have been assumed to serve as static linkers as KCl-
pretreated peroxisomal eluate fractions reacted with antibodies
against CLIP-115 [10], a brain-enriched protein responsible for bind-
ing of dendritic lamellar bodies to microtubules [53]. Furthermore,
direct binding of the peroxisomal membrane protein PEX14 to tubu-
lin has been demonstrated recently and PEX14-deﬁcient human
ﬁbroblasts showed severe reduction in motility of peroxisomal
structures [54]. The authors concluded that PEX14 serves as a perox-
isomal anchor to microtubules and thereby enables peroxisomal
motility.
KifC3 did not seem to act as a typical minus-motor on peroxisomal
transport and therefore one can speculate that KifC3 could play a similar
role in statically connecting peroxisomes to microtubules. This seems
reasonable as only a small part of peroxisomes performs long-range
directed movements whereas most peroxisomes are statically linked
to microtubules [4,5]. The observed perinuclear retraction of mitochon-
dria and ER after KifC3 knockdown (Fig. 6) also supports the idea of
KifC3 acting as a static microtubule linker on these organelles. It is
tempting to speculate that PEX1 could serve as peroxisomal adaptor
for KifC3 via the peroxins PEX6 and PEX26.
We showhere interaction of KifC3with the AAA-ATPase PEX1 in vitro
using coimmunoprecipitation (CoIp) (Fig. 1B) aswell as in vivo in human
ﬁbroblasts lacking PEX1. In vivo, KifC3 was not detected at peroxisomes
but transiently expressed PEX1-myc colocalized with overexpressed
KifC3 at microtubules (Fig. 1A). As the CoIp was conducted using COS-
7 cell lysates overexpressing PEX1-myc and humanKifC3, indirect inter-
action via another protein could be possible. The CoIp conditions needed
to be precisely adapted in order to detect KifC3 in the eluates suggesting
weak, transient binding. The fact that KifC3 has been detected in a yeast
two-hybrid screen with PEX1 also indicates an interaction of these
proteins.
The AAA-ATPases PEX1 and PEX6 are responsible for recycling of the
peroxisomalmatrix protein import receptor PEX5 from the peroxisomal
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located in the cytosol and are anchored at the peroxisomal membrane
by the membrane protein PEX26 [57]. PEX1-lacking human ﬁbroblasts
(ΔPEX1) are deﬁcient in peroxisomal matrix protein import and harbor
dysfunctional empty membrane structures, so called “ghosts”. The
number and distribution of these “ghosts” are disturbed, often resulting
in clustering at different cellular areas. Nguyen et al. showed reduced
binding of peroxisomes to microtubules in ΔPEX1 cells compared to
normal ﬁbroblasts [44] which would support the idea of PEX1 acting
as a peroxisomal adaptor protein for KifC3. However, we were able to
observe long-range directed movements of peroxisomal “ghosts” by
YFP-detection after PEX16-YFP expression (data not shown) and also
another study did not detect any decrease of peroxisomal motility in
ΔPEX1 cells compared to normal ﬁbroblasts [54]. In addition, it has
been demonstrated that expression of PEX11β in ΔPEX1 cells not only
increased the numbers of peroxisomal structures by stimulating prolif-
eration [58–60], but also resulted in a uniform distribution of these
“ghosts” in the cytoplasm [44]. These two examples indicate that the
PEX1 KIFC3 binding does not constitute the only connection of peroxi-
somes to microtubules. The expression of PEX16-YFP or PEX11-myc
might trigger different adapters. Furthermore, the yeast two-hybrid
screen using PEX1 as bait identiﬁed C-terminal residues of KifC3
as binding region (data not shown). Motor proteins normally bind to
microtubules via their motor domain, which is located at the C-
terminus in C-kinesins like KifC3, andbind their cargoes at the cargo bind-
ing domain, usually located at the N-terminus of the protein, often via
adaptor proteins. Therefore, binding of PEX1 to a C-terminal area of
KifC3 points more to a regulating function on KifC3.
4.3. KifC3 acts as a break on dynein-based organelle transport
KifC3 seems to selectively affect peroxisomal minus-end directed
motility and therefore might be directly involved in kinesin-1 and
dynein dependent peroxisomal transport. Knockdown of KifC3 resulted
in an increase of cells with perinuclear-clustered peroxisomes most
probably due to enhanced minus-motor activity at peroxisomes. The
used siRNA targeting KifC3-mRNA did not reduce Kif5B-mRNA (Fig. 3A)
and also did not constantly upregulate dynein-mRNA (data not shown).
As KifC3 did not seem to act as a typical motor protein on peroxisomes,
KifC3may play a regulatory role during peroxisomal minus-end directed
transport. Regulation of peroxisomal motility by a GTP-binding protein
via a peroxisome-speciﬁc signaling pathway has been reported [61,62]
and the small GTPase RhoA seems to be involved in association of per-
oxisomes to microtubules [63].
Until now the only detected minus-motor protein acting on peroxi-
somes is cytoplasmic dynein [6–8]. Based on the observed peroxisomal
KifC3 knockdown phenotype, it is tempting to speculate that binding of
KifC3 to peroxisomes could constrict dynein function e.g. by simple
steric hindrance. Existence of such mechanisms to regulate organelle
transport has already been discussed before [64,65]. KifC3 could block
the pathway in minus-end direction at microtubules and therefore
could function as a break until minus-end directed peroxisomal trans-
port is activated. This process could be regulated by phosphorylation,
asWestern blot analysis of different cell lysates usingα-KifC3 antibodies
partly detected an additional band potentially representing phosphory-
lated KifC3 (Fig. 2B). In fact, phosphoproteom studies using puriﬁed
mitotic spindle proteins of HELA cells revealed KifC3 phosphorylation
[66]. Activation of minus-end directed peroxisomal transport could
lead to release of KifC3 into the cytosol and dynein-mediated minus-
end directed transport of peroxisomes. If KifC3 levels were reduced
due to siRNA treatment at least this regulation of peroxisomal transport
would be missing. This would cause enhanced minus-end directed
motility of peroxisomes leading to clustering of peroxisomes at the
centrosome.
Such selective blocking functions on motor proteins have been
postulated before. Overexpression of GMAP-210, anchoring the CGN(cis-Golgi network) to microtubules [67], increased the Golgi complex
in size whereas expression of a dominant negative GMAP-210 mutant
resulted in Golgi size reduction [68]. It was concluded that GMAP-210
may regulate the size of the Golgi complex by blocking anterograde
vesicle transport from the CGN to the medial Golgi after binding of the
CGN via GMAP-210 to microtubules. In contrast, the microtubule-
associated protein Tau selectively inhibited kinesin-1 motor activity
[69]. Overexpression of Tau in N2a cells reduced plus-end directed
peroxisomal motility and resulted in clustering of peroxisomes at the
MTOC (microtubule organizing center) [70].5. Conclusion
We show here for the ﬁrst time involvement of the C-terminal
kinesin KifC3 in microtubule-based peroxisomal transport. Knockdown
of KifC3 using siRNA increased the amount of cells with perinuclear-
clustered peroxisomes. We consider a role of KifC3 as static linker
between peroxisomes and microtubules unlikely and rather favor a
role of KifC3 in minus-end directed peroxisomal transport regulation
by acting as a break for dynein motor protein action. Knockdown of
KifC3 would then cause enhanced minus-end directed motility of
peroxisomes leading to the observed clustering of peroxisomes at cen-
trosomes. Furthermore, interaction of PEX1 with KifC3 could constitute
another regulating element for peroxisomal motility e.g. by competing
with KifC3 binding to microtubules. The results of this study indicate
that microtubule-based peroxisomal transport is much more complex
than expected so far and that numerous other factors are involved in
these processes besides the motor proteins kinesin-1 and dynein.Acknowledgements
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